David Juurlink

David Juurlink
Born1968 (age 57–58)
New Glasgow, Nova Scotia, Canada
EducationDalhousie University
OccupationPhysician

David Juurlink (/ˈjʊərlɪŋk/ YURE-link; born New Glasgow, Nova Scotia) is a Canadian pharmacologist and internist. He is head of the Clinical Pharmacology and Toxicology division at Sunnybrook Health Sciences Centre in Toronto, Ontario, as well as a medical toxicologist at the Ontario Poison Centre and a scientist at the Institute for Clinical Evaluative Sciences. He is known for researching adverse effects caused by drug interactions, with some of this research funded by a New Investigator Award from the Canadian Institutes for Health Research. He has been critical of regular prescribing of opioids like Tramadol and fentanyl. In June 2017, he published a letter analyzing citations to "Addiction Rare in Patients Treated with Narcotics", a 1980 letter in The New England Journal of Medicine that has often been cited to claim that opioids like OxyContin are rarely addictive.

References

  1. ↑ "David Juurlink". Archived from the original on 30 October 2020. Retrieved 26 October 2020.
  2. ↑ "Meet the Expert Video Series featuring ICES senior scientist Dr. David Juurlink". YouTube. June 2, 2015. Retrieved 29 November 2022.
  3. ↑ "We are Sunnybrook". The Globe and Mail. 7 May 2011. Retrieved 24 June 2017.
  4. ↑ Kirkup, Kristy (26 February 2017). "Health Canada's position on opioid Tramadol is indefensible: doctor". The Globe and Mail. Retrieved 24 June 2017.
  5. ↑ Kirkey, Sharon (7 April 2016). "Doctors' reckless prescribing of fentanyl largely to blame for deadly overdoses: expert". National Post. Retrieved 24 June 2017.
  6. ↑ "Dr. David Juurlink says colleagues must accept blame for fentanyl ODs". CBC News. 24 August 2015. Retrieved 24 June 2017.
  7. ↑ "Opioid crisis: The letter that started it all". BBC News. 3 June 2017. Retrieved 24 June 2017.